1. Home
  2. NLSP vs FTFT Comparison

NLSP vs FTFT Comparison

Compare NLSP & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • FTFT
  • Stock Information
  • Founded
  • NLSP 2015
  • FTFT N/A
  • Country
  • NLSP Switzerland
  • FTFT United States
  • Employees
  • NLSP N/A
  • FTFT N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • FTFT Business Services
  • Sector
  • NLSP Health Care
  • FTFT Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • NLSP 8.2M
  • FTFT 8.4M
  • IPO Year
  • NLSP 2021
  • FTFT N/A
  • Fundamental
  • Price
  • NLSP $0.20
  • FTFT $0.44
  • Analyst Decision
  • NLSP Hold
  • FTFT
  • Analyst Count
  • NLSP 1
  • FTFT 0
  • Target Price
  • NLSP N/A
  • FTFT N/A
  • AVG Volume (30 Days)
  • NLSP 29.3M
  • FTFT 128.8K
  • Earning Date
  • NLSP 07-23-2024
  • FTFT 08-19-2024
  • Dividend Yield
  • NLSP N/A
  • FTFT N/A
  • EPS Growth
  • NLSP N/A
  • FTFT N/A
  • EPS
  • NLSP N/A
  • FTFT N/A
  • Revenue
  • NLSP N/A
  • FTFT $36,594,555.00
  • Revenue This Year
  • NLSP N/A
  • FTFT N/A
  • Revenue Next Year
  • NLSP N/A
  • FTFT N/A
  • P/E Ratio
  • NLSP N/A
  • FTFT N/A
  • Revenue Growth
  • NLSP N/A
  • FTFT 53.89
  • 52 Week Low
  • NLSP $0.11
  • FTFT $0.40
  • 52 Week High
  • NLSP $1.21
  • FTFT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 54.22
  • FTFT 29.24
  • Support Level
  • NLSP $0.18
  • FTFT $0.44
  • Resistance Level
  • NLSP $0.22
  • FTFT $0.54
  • Average True Range (ATR)
  • NLSP 0.04
  • FTFT 0.07
  • MACD
  • NLSP -0.00
  • FTFT 0.00
  • Stochastic Oscillator
  • NLSP 16.51
  • FTFT 18.45

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.

Share on Social Networks: